Source:http://linkedlifedata.com/resource/pubmed/id/21793843
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2011-7-28
|
pubmed:abstractText |
The 21st century will see improvements in the quality of human life. The development of new therapeutic technologies will prevent prevalent diseases and enable recovery from currently incurable diseases. The development of cell and tissue replacement therapies using stem cells and their progenitors will accelerate the development of causative treatments. The effort expended thus far in developing cell therapies has revealed many technical limitations. Thus, we must explore conceptual changes in the feasibility of stem cell therapy. This paper introduces the current limitations to stem cell engineering and ways to overcome these limitations, which will provide new insight into their clinical application.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1749-6632
|
pubmed:author | |
pubmed:copyrightInfo |
© 2011 New York Academy of Sciences.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
1229
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
89-98
|
pubmed:meshHeading | |
pubmed:year |
2011
|
pubmed:articleTitle |
Stem cell engineering: limitation, alternatives, and insight.
|
pubmed:affiliation |
WCU Biomodulation and Department of Agricultural Biotechnology, Seoul National University, Seoul, Korea. limjm@snu.ac.kr
|
pubmed:publicationType |
Journal Article,
Review
|